Condition
Biliary Tract Disease
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 1 (1)
P 2 (1)
Trial Status
Completed3
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT02524418Not ApplicableCompletedPrimary
Clinical Utility of ERCP Guided Cholangiopancreatoscopy With the SpyGlass DS
NCT02118493Not ApplicableWithdrawnPrimary
Endo-biliary Laser Excision of Biliary Stenoses
NCT00124202Phase 1CompletedPrimary
Effect of a Fatty Meal on Endoscopic Retrograde Cholangiopancreatography (ERCP)
NCT00201305Phase 2CompletedPrimary
Gemcitabine Plus High-Dose 5-Fu/Leucovorin in the Treatment of Advanced or Metastatic Carcinoma of the Biliary Tract
Showing all 4 trials